Methods for the drug effectiveness review project

Marian S. McDonagh, Daniel E. Jonas, Gerald Gartlehner, Alison Little, Kim Peterson, Susan Carson, Mark Gibson, Mark Helfand

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations

Abstract

The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described.

Original languageEnglish (US)
Article number140
JournalBMC Medical Research Methodology
Volume12
DOIs
StatePublished - 2012

ASJC Scopus subject areas

  • Epidemiology
  • Health Informatics

Fingerprint Dive into the research topics of 'Methods for the drug effectiveness review project'. Together they form a unique fingerprint.

Cite this